Shenyang Xingqi Pharmaceutical Co.,Ltd

Shenzhen Stock Exchange 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd Free Cash Flow for the year ending December 31, 2023: USD 7.83 M

Shenyang Xingqi Pharmaceutical Co.,Ltd Free Cash Flow is USD 7.83 M for the year ending December 31, 2023, a 516.92% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Shenyang Xingqi Pharmaceutical Co.,Ltd Free Cash Flow for the year ending December 31, 2022 was USD -1.88 M, a -105.63% change year over year.
Shenyang Xingqi Pharmaceutical Co.,Ltd Free Cash Flow for the year ending December 31, 2021 was USD 33.35 M, a 1,454.14% change year over year.
Shenyang Xingqi Pharmaceutical Co.,Ltd Free Cash Flow for the year ending December 31, 2020 was USD 2.15 M, a 263.97% change year over year.
Shenyang Xingqi Pharmaceutical Co.,Ltd Free Cash Flow for the year ending December 31, 2019 was USD 589.55 K, a 417.28% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 300573.SZ

Shenyang Xingqi Pharmaceutical Co.,Ltd

CEO	Ms. E. Gao
IPO Date	Dec. 9, 2016
Location	China
Headquarters	No. 68, Lishui Street
Employees	1,995
Sector	Health Care
Industries Pharmaceuticals Cosmetics Eyewear

Description

Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.

Key trends

Past 5 years